Conversely, mutational inactivation of p53/Lats2 or LKB1/AMPK axes in human cancer critically allows DVL to become a potent activator of the canonical Wnt pathway without suppression of nuclear YAP (Supplementary Fig. 9d). Here, TP53 is linked to cancer.